| Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance T Dogru, A Sonmez, I Tasci, E Bozoglu, MI Yilmaz, H Genc, G Erdem, ... Diabetes research and clinical practice 76 (1), 24-29, 2007 | 377 | 2007 |
| Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus G Erdem, T Dogru, I Tasci, A Sonmez, S Tapan Experimental and clinical endocrinology & diabetes 116 (05), 289-292, 2008 | 213 | 2008 |
| Plasma apelin and ADMA Levels in patients with essential hypertension A Sonmez, G Celebi, G Erdem, S Tapan, H Genc, I Tasci, CN Ercin, ... Clinical and experimental hypertension 32 (3), 179-183, 2010 | 138 | 2010 |
| Plasma apelin is lower in patients with elevated LDL-cholesterol I Tasci, T Dogru, I Naharci, G Erdem, MI Yilmaz, A Sonmez, N Bingol, ... Experimental and clinical endocrinology & diabetes 115 (07), 428-432, 2007 | 114 | 2007 |
| LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia I Tasci, G Erdem, G Ozgur, S Tapan, T Dogru, H Genc, C Acikel, ... Atherosclerosis 204 (1), 222-228, 2009 | 104 | 2009 |
| The effect of activated protein C on experimental acute necrotizing pancreatitis L Yamenel, MR Mas, B Comert, AT Isik, S Aydin, N Mas, S Deveci, ... Critical care 9 (3), R184, 2005 | 86 | 2005 |
| The effect of taurine treatment on oxidative stress in experimental liver fibrosis MR Mas, B Comert, K Oncu, SA Vural, C Akay, I Tasci, E Ozkomur, ... Hepatology research 28 (4), 207-215, 2004 | 83 | 2004 |
| Ultrastructural changes in hepatocytes after taurine treatment in CCl4 induced liver injury I Tasci, N Mas, MR Mas, M Tuncer, B Comert World Journal of Gastroenterology: WJG 14 (31), 4897, 2008 | 74 | 2008 |
| Peripheral artery disease assessed by ankle-brachial index in patients with established cardiovascular disease or at least one risk factor for atherothrombosis-CAREFUL Study: A … AK Bozkurt, I Tasci, O Tabak, M Gumus, Y Kaplan BMC cardiovascular disorders 11 (1), 4, 2011 | 72 | 2011 |
| Ursodeoxycholic acid treatment improves hepatocyte ultrastructure in rat liver fibrosis N Mas, I Tasci, B Comert, R Ocal, MR Mas World Journal of Gastroenterology: WJG 14 (7), 1108, 2008 | 61* | 2008 |
| Plasma visfatin levels in young male patients with uncomplicated and newly diagnosed hypertension T Dogru, A Sonmez, I Tasci, MI Yilmaz, G Erdem, H Erturk, N Bingol, ... Journal of human hypertension 21 (2), 173-173, 2007 | 55 | 2007 |
| The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus G Erdem, T Dogru, I Tasci, E Bozoglu, O Muhsiroglu, S Tapan, CN Ercin, ... diabetes research and clinical practice 82 (2), 214-218, 2008 | 52 | 2008 |
| Decreased small dense LDL levels in Gilbert's syndrome S Tapan, N Karadurmus, T Dogru, CN Ercin, I Tasci, C Bilgi, I Kurt, ... Clinical biochemistry 44 (4), 300-303, 2011 | 50 | 2011 |
| Maprotiline induced weight gain in depressive disorder: changes in circulating ghrelin and adiponectin levels and insulin sensitivity M Pinar, M Gulsun, I Tasci, A Erdil, E Bolu, C Acikel, A Doruk Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (1), 135-139, 2008 | 50 | 2008 |
| Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis I Tasci, MR Mas, SA Vural, S Deveci, B Comert, G Alcigir, N Mas, C Akay, ... World Journal of Gastroenterology: WJG 13 (23), 3237, 2007 | 44 | 2007 |
| Rat liver fibrosis regresses better with pegylated interferon α2b and ursodeoxycholic acid treatments than spontaneous recovery II Tasci, MR Mas, SA Vural, B Comert, G Alcigir, M Serdar, N Mas, AT Isik, ... Liver International 26 (2), 261-268, 2006 | 44 | 2006 |
| Clinical characteristics and outcomes of COVID‐19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia) A Sonmez, I Demirci, C Haymana, I Tasci, S Dagdelen, S Salman, N Ata, ... Journal of diabetes 13 (7), 585-595, 2021 | 43 | 2021 |
| Chitotriosidase activity predicts endothelial dysfunction in type-2 diabetes mellitus A Sonmez, C Haymana, S Tapan, U Safer, G Celebi, O Ozturk, H Genc, ... Endocrine 37, 455-459, 2010 | 42 | 2010 |
| Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: a link to protection against atherosclerosis? S Tapan, T Dogru, I Tasci, CN Ercin, T Ozgurtas, MK Erbil Clinical biochemistry 42 (9), 791-795, 2009 | 41 | 2009 |
| Allopurinol in rat chronic pancreatitis: effects on pancreatic stellate cell activation I Tasci, S Deveci, AT Isik, B Comert, C Akay, N Mas, V Inal, L Yamanel, ... Pancreas 35 (4), 366-371, 2007 | 40 | 2007 |
Alper SonmezAnkara Guven HospitalVerified email at guven.com.tr
